Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,888.80 -1,908.48 (-3.04%) CMC Crypto 200
1,262.46 -95.55 (-7.04%)
Churchill Capital Corp VII (CVII)
| Previous close | 10.71 |
| Open | 10.73 |
| Bid | 10.70 x 200 |
| Ask | 10.76 x 300 |
| Day's range | 10.72 - 10.73 |
| 52-week range | 10.16 - 10.85 |
| Volume | |
| Avg. volume | 154,284 |
| Market cap | 981.569M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 1,072.00 |
| EPS (TTM) | 0.01 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireSpecial Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Warrant Holder Meeting to Approve Warrant Amendment Scheduled for May 21, 2024
Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it has scheduled a special meeting of Churchill VII stockholders and a meeting of Churchill VII warrant holders for May 21, 2024 in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill VII (the "Business Combination"). T
PR NewswireChurchill Capital Corp VII Announces Continuation of $1,000,000 Monthly Sponsor Contribution
Churchill Capital Corp VII ("Churchill VII") announced today actions being undertaken in advance of a special meeting of its stockholders (the "Special Meeting") on February 8, 2024, at which Churchill VII's stockholders will be asked to vote on, among other things, a proposal to amend Churchill VII's amended and restated certificate of incorporation to extend the date by which Churchill VII has to consummate its business combination with CorpAcq Holdings Limited ("CorpAcq") from February 17, 20
PR NewswireChurchill Capital Corp VII Announces Intention to Transfer Listing to Nasdaq
Churchill Capital Corp VII ("Churchill VII") (NYSE: CVII), a special purpose acquisition company, announced today that it plans to transfer the listing of its shares of Class A common stock, public warrants and public units from the New York Stock Exchange ("NYSE") to Nasdaq Global Market ("Nasdaq").
